Medical Image Analysis Software Market Size - Global Forecast to 2022

The report "Medical Image Analysis Software Market by Type (Standalone), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Dental, Oncology, Nephrology), End User (Hospital, Diagnostic Centre, Research) - Global Forecasts to 2022" The medical image analysis software market is expected to reach USD 3.88 billion by 2022 from USD 2.6 billion in 2017, at a CAGR of 8.2% during the forecast period. The growth of the market is attributed to technological advancements in medical imaging systems & analysis software, growing public- and private-sector investments in the medical imaging market, increasing use of imaging equipment due to rising prevalence of chronic diseases, fusion of imaging technologies, and growing applications of computer-aided diagnosis. Growing need for automated image analysis tools, rising adoption of cloud-based imaging solutions, and untapped emerging markets are expected to offer significant growth opportunities for manufacturers in the coming years.
                                         
Browse 303 Market Data Tables and 43 Figures spread through 313 Pages and in-depth TOC on "Medical Image Analysis Software Market “.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=846


Integrated software to dominate the market in 2017
Based on type, the medical image analysis software market is segmented into integrated and standalone software. In 2017, the integrated software segment is expected to account for the largest share of the medical image analysis software market. The compatibility of the software with the equipment is examined by the manufacturer beforehand and easy handling and fast processing are additional factors that contribute to the adoption of integrated image analysis software. However, the standalone software segment is expected to grow at the highest CAGR during the forecast period. Standalone software offers high flexibility and easy-to-use tools to inspect, evaluate, and process imaging data. These advantages are driving its growth in the market.

On the basis of end user, hospitals are projected to grow at the highest CAGR
By end user, the medical image analysis software market is segmented into hospitals, diagnostic centers, and research centers. Hospitals are expected to register the highest CAGR during the forecast period. The greater use of medical imaging software in hospitals & the higher installed base of diagnostic imaging systems (as compared to diagnostic and research centers) and high patient inflow (as compared to diagnostic centers) are expected to boost the demand for medical image analysis software in this segment.

North America to dominate the market followed by Europe
In 2017, North America is expected to account for the largest share of the market. The high growth of the North American market is attributed to the factors such as the growing geriatric population, high incidence/prevalence of various diseases, the large number of imaging centers in this region, ongoing research, fast adoption of technologically advanced imaging systems, and increasing awareness about the benefits of early disease diagnosis. In 2017, Europe is expected to hold the second largest share of this market. Factors such as rising incidence of chronic diseases and injuries, increasing demand for non-radiation diagnostic solutions, technological advancements and new product launches, large number of ongoing research activities, and increasing government and public-private investments are expected to fuel the market growth in this region.

Read More:- https://www.marketsandmarkets.com/PressReleases/medical-image-analysis.asp

The medical image analysis software market is highly competitive with the presence of several small and big players. Some of the players in the medical image analysis software market include AGFA Healthcare (Belgium), AQUILAB (France), Carestream Health, Inc. (US), Esaote S.p.A (Italy), GE Healthcare (US), Image Analysis (UK), INFINITT Healthcare Co, Ltd. (South Korea), Merge Healthcare, Inc. (US), MIM Software Inc. (US), Mirada Medical Limited (UK), Philips Healthcare (Netherlands), ScienceSoft USA Corporation (US), Siemens Healthineers (Germany), Toshiba Medical Systems Corporation (Japan), and Xinapse Systems Ltd (UK).

Mobile Health Solutions Market by Apps, Connected Devices & Services - 2022

The research report "mHealth Solutions Market by Connected Devices (Blood Pressure Monitor, Glucose Meter, Peak Flow Meter) Apps (Weight Loss, Woman Health, Personal Health Record, & Medication) Services (Diagnostic, Remote Monitoring, Consultation) - Global Forecasts to 2022", The global mHealth solutions market is expected to reach USD 90.49 Billion by 2022 from USD 21.17 Billion in 2017, at a CAGR of 33.7%.

Factors driving market growth include the increasing penetration of smartphones, tablets, and other mobile platforms, increasing utilization of connected devices and mHealth apps for the management of chronic diseases, and the rising cost containment in healthcare delivery. In addition, the penetration of 3G and 4G networks for uninterrupted healthcare services and rising focus on patient-centric healthcare delivery further increases the demand for mHealth solutions in the healthcare industry.

By product and service, the connected devices segment accounted for the largest share of the market in 2016
On the basis of product and service, the mHealth solutions market is segmented into connected medical devices, mHealth applications, and mHealth services. In 2016, connected medical devices accounted for the largest share of the mHealth solutions market, mainly due to the increasing incidence of chronic diseases and lifestyle-associated diseases requiring continuous health monitoring and the shifting consumer preferences towards a healthier lifestyle.

Browse and in-depth TOC on “mHealth Solutions Market”

313 - Tables

46 - Figures

375 - Pages 

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232

Within connected medical devices segment, the vital signs monitoring devices accounted for the largest share of the market
The connected medical devices market is further segmented into consumer health devices and clinical devices. Clinical devices segment is categorized into vital signs monitoring devices, peak flow meters, neurological monitoring devices, sleep apnea monitors, multi-parameter trackers, and others. In 2016, vital signs monitoring devices accounted for the largest share of of the global connected medical devices market. This is attributed to the rise in prevalence and incidence of diabetes and cardiovascular diseases across the globe and increasing adoption of continuous glucose monitoring (CGM) systems and various health monitoring devices.

Within mHealth applications segment, the healthcare applications accounted for the largest share of the market
The mHealth applications market is segmented into healthcare applications (designed for patients) by activity, and medical applications (designed for professionals). In 2016, the healthcare applications accounted for the largest share of the mHealth applications market. This growth is attributed to the factors such as increasing number of people using smart phones, the increasing preference for personal health and wellness app for self-health management and the increasing need for tracking daily activities and various health conditions of patients leading to the rising adoption of healthcare apps.

Within mHealth services segment, the remote monitoring services is expected to register the highest CAGR during the forecast period
On the basis of mHealth services, the market is categorized into remote monitoring, diagnosis services, treatment services, consultation services, fitness and wellness services, prevention services and healthcare system strengthening services. The remote monitoring services segment is expected to register the highest CAGR in the mHealth solutions market. The large share can be attributed to the increasing adoption of remote monitoring solutions by patients in remote rural areas and technological advancements in medicine and telecommunication.

Read more:-  https://www.marketsandmarkets.com/PressReleases/mhealth-apps-and-solutions.asp

North America dominated the market in 2016
In 2016, North America dominated the global mHealth solutions market. The increasing demand for better healthcare services, government initiatives for digital health, stringent regulations regarding patient safety and patient care, and increasing number of smartphone users coupled with the rising awareness of self-health management are driving the growth of the mHealth solutions market in this region.

The key players in the mHealth solutions market are Medtronic plc (Ireland), Apple, Inc. (U.S.), AirStrip Technologies, Inc. (U.S.), AliveCor, Inc. (U.S.), LifeWatch AG (Switzerland), Nike Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Jawbone (U.S.), OMRON Corporation (Japan), Withings (France), BioTelemetry Inc. (U.S.), athenahealth, Inc. (U.S.), AgaMatrix, Inc. (U.S.), iHealth Lab, Inc. (U.S.), AT&T (U.S.), Qualcomm (U.S.), Cerner Corporation (U.S.), and Cisco Systems, Inc. (U.S.), and Nokia Corporation (Finland).

Leading Players in the Nerve Repair and Regeneration Market

The research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022", The nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

By neurostimulation and neuromodulation device product, the internal neurostimulation device segment is expected to dominate the market in 2017

On the basis of neurostimulation and neuromodulation device product is subsegmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017. This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883

By end user, the hospitals and clinics segment is expected to dominate the market in 2017
In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

Browse and in-depth TOC on “Nerve Repair and Regeneration Market”

83 - Tables

31 - Figures

122 - Pages

Asia offers lucrative growth opportunities By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to register the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing neurological disorder in the region are some major factors driving the high growth of this regional segment.

Know more: - https://www.marketsandmarkets.com/PressReleases/nerve-repair-regeneration.asp

Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

Stem Cell Therapy Market by Type & Therapeutic Applications - 2021

The research report "Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).


This report studies the stem cell therapy market during the forecast period of 2016 to 2021. The market is expected to reach USD 145.8 Million by 2021, growing at a CAGR of 11.0% during the forecast period. Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.


Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48 


On the basis of type, the global stem cell therapy market is divided into two major categories, namely, allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy segment is expected to command the largest share in the global stem cell therapy market in 2016. This large share can primarily be attributed to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, and growing number of clinical trials related to allogeneic stem cell therapies.

Browse and in-depth TOC on “Stem Cell Therapy Market”

60 - Tables

37 - Figures

120 - Pages

 

On the basis of therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications. The musculoskeletal disorders segment is expected to command the largest share of the global stem cell therapy market in 2016. This large share can be attributed to the rising availability of stem cell-based products for the treatment of musculoskeletal disorders, high prevalence of musculoskeletal disorders and bone & joint diseases, and growing patient preference for effective & early treatment strategies.

Know more : https://www.marketsandmarkets.com/PressReleases/stem-cells-market.asp 

North America is expected to be the largest regional segment in the global stem cell therapy market in 2016, followed by Asia-Pacific. In addition, the North American stem cell therapy market is expected to be the fastest growing region during the forecast period. Factors such as growing awareness related to the therapeutic potency of stem cells, increasing number of clinical trials for stem cell-based products, and increasing public-private funding & research grants are driving the growth of this market.